|
| PIK3CA* | c-MET* | c-KIT* | |||||||
| n | % | Sig | n | % | Sig | n | % | Sig | ||
| Age | <50 | 3 | 37.5% | 0.247 | 4 | 40.0% | 0.239 | 1 | 20.0% | 0.085 |
| ³50 | 5 | 62.5% | 6 | 60.0% | 4 | 80.0% | ||||
| Tumor Size | <2 cm | 4 | 50.0% | 0.214 | 4 | 40.0% | 0.344 | 3 | 60.0% | 0.213 |
| 2 - 5 cm | 4 | 50.0% | 6 | 60.0% | 2 | 40.0% | ||||
| >5 cm | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | ||||
| Necrosis | Absent | 5 | 62.5% | 0.770 | 5 | 50.0% | 0.484 | 2 | 40.0% | 0.350 |
| Present | 3 | 37.5% | 5 | 50.0% | 3 | 60.0% | ||||
| Grade | Grade 1 | 1 | 12.5% | 0.741 | 1 | 10.0% | 0.527 | 0 | 0.0% | 0.131 |
| Grade 2 | 3 | 37.5% | 4 | 40.0% | 1 | 20.0% | ||||
| Grade 3 | 4 | 50.0% | 5 | 50.0% | 4 | 80.0% | ||||
| LVI | Absent | 5 | 62.5% | 0.770 | 5 | 50.0% | 0.484 | 2 | 40.0% | 0.350 |
| Present | 3 | 37.5% | 5 | 50.0% | 3 | 60.0% | ||||
| LNM | Negative | 0 | 0.0% | 0.018 | 2 | 20.0% | 0.565 | 2 | 40.0% |
0.150
|
| Positive < 3 | 2 | 25.0% | 3 | 30.0% | 0 | 0.0% | ||||
| Positive ³ 3 | 6 | 75.0% | 5 | 50.0% | 3 | 60.0% | ||||
| Stage | Stage 1 | 0 | 0.0% | 0.034 | 0 | 0.0% | 0.014 | 2 | 40.0% | 0.092 |
| Stage 2 | 1 | 12.5 % | 2 | 20.0% | 0 | 0 % | ||||
| Stage 3 | 3 | 37.5 % | 3 | 30.0% | 2 | 40.0% | ||||
| Stage 4 | 4 | 50.0% | 5 | 50.0% | 1 | 20.0% | ||||
| PTEN | Negative | 8 | 100.0% | 0.046 | 8 | 80.0% | 0.633 | 4 | 80.0% | 0.772 |
| Positive | 0 | 0.0% | 2 | 20.0% | 1 | 20.0% | ||||
| TNBC | TNBC | 3 | 37.5% | 0.155 | 5 | 50.0% | 0.003 | 3 | 60.0% | 0.015 |
| Non-TNBC | 5 | 62.5% | 5 | 50.0% | 2 | 40.0% | ||||